Finance

Lists
600511:SHA
China National Medicines Corp Ltd
CNÂ¥26.89
-0.11%
(-0.030) 1D
Sep 9, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600511...
Open
CNÂ¥26.87
High
CNÂ¥26.93
Low
CNÂ¥26.72
Mkt. cap
20.28B
Avg. vol.
4.75M
Volume
1.91M
Dividend
2.98%
Quarterly dividend
CNÂ¥0.20
Ex-dividend date
Jun 18, 2026
P/E ratio
10.52
52-wk high
CNÂ¥31.18
52-wk low
CNÂ¥25.11
EPS
CNÂ¥2.56
Shares outstanding
764.40M
No. of employees
3K
Open
CNÂ¥26.87
High
CNÂ¥26.93
Low
CNÂ¥26.72
Mkt. cap
20.28B
Avg. vol.
4.75M
Volume
1.91M
Dividend
2.98%
Quarterly dividend
CNÂ¥0.20
Ex-dividend date
Jun 18, 2026
P/E ratio
10.52
52-wk high
CNÂ¥31.18
52-wk low
CNÂ¥25.11
EPS
CNÂ¥2.56
Shares outstanding
764.40M
No. of employees
3K
About China National Medicines Corp Ltd
CEO-
Employees3.02K
FoundedDec 21, 1999
Headquarters-
SectorHealth care provider
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.75B
13.09B
13.56B
13.17B
Cost of goods sold
12.81B
12.13B
12.73B
12.40B
Cost of revenue
12.81B
12.13B
12.73B
12.40B
Research and development expenses
15.58M
25.71M
12.76M
12.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
287.32M
395.22M
244.70M
279.19M
Operating expense
409.52M
426.92M
348.02M
329.71M
Total operating expenses
13.22B
12.56B
13.08B
12.73B
Operating income
524.04M
528.52M
478.71M
439.72M
Other non operating income
-7.44M
3.63M
239.24K
-1.14M
EBT including unusual items
707.16M
666.40M
606.78M
536.04M
EBT excluding unusual items
673.52M
659.60M
610.48M
604.08M
Income tax expense
142.75M
132.89M
115.27M
153.31M
Effective tax rate
20.19%
19.94%
19.00%
28.60%
Other operating expenses
41.53M
36.99M
31.36M
36.10M
Net income
543.72M
504.33M
474.26M
405.51M
Net profit margin
3.96%
3.85%
3.50%
3.08%
Earnings per share
0.72
0.66
-
-
Interest and investment income
157.33M
137.32M
137.65M
166.87M
Interest expense
-5.20M
-7.00M
-6.11M
-4.67M
Net interest expenses
152.13M
130.32M
131.54M
162.19M
Depreciation and amortization charges
-
-
-
-
EBITDA
551.55M
558.14M
508.33M
467.75M
Gain or loss from assets sale
548.00
-212.18K
-
20.11K
AI content may include mistakes. Learn more
Google apps